Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

Niharendu Ghara; Vaskar Saha

doi:10.1016/S2352-3026(23)00091-1

Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

Niharendu Ghara, Vaskar Saha

Division of Cancer Sciences (L5)

Tata Medical Center

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e391-e393
Journal	The Lancet. Haematology
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/S2352-3026(23)00091-1
Publication status	Published - Jun 2023

Keywords

Humans
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
Arabinonucleosides/therapeutic use
T-Lymphocytes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2352-3026(23)00091-1

Cite this

@article{730ce22b23a549f492a1b39725627add,

title = "Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia",

keywords = "Humans, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Arabinonucleosides/therapeutic use, T-Lymphocytes",

author = "Niharendu Ghara and Vaskar Saha",

year = "2023",

month = jun,

doi = "10.1016/S2352-3026(23)00091-1",

language = "English",

volume = "10",

pages = "e391--e393",

journal = "The Lancet. Haematology",

issn = "2352-3026",

publisher = "The Lancet",

number = "6",

}

TY - JOUR

T1 - Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

AU - Ghara, Niharendu

AU - Saha, Vaskar

PY - 2023/6

Y1 - 2023/6

KW - Humans

KW - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Arabinonucleosides/therapeutic use

KW - T-Lymphocytes

U2 - 10.1016/S2352-3026(23)00091-1

DO - 10.1016/S2352-3026(23)00091-1

M3 - Article

C2 - 37167993

SN - 2352-3026

VL - 10

SP - e391-e393

JO - The Lancet. Haematology

JF - The Lancet. Haematology

IS - 6

ER -